中文 | English
Return
Total: 110 , 1/11
Show Home Prev Next End page: GO
MeSH:(Carcinoma, Renal Cell/*metabolism/*pathology)

4.Cyclooxygenase-2 and p53 Expression as Prognostic Indicators in Conventional Renal Cell Carcinoma.

Dae Sung CHO ; Hee Jae JOO ; Dong Keun OH ; Ji Hun KANG ; Young Soo KIM ; Kyi Beom LEE ; Se Joong KIM

Yonsei Medical Journal 2005;46(1):133-140

5.Optimal margin in nephron-sparing surgery for renal cell carcinoma 4 cm or less in diameter.

Quan-lin LI ; Hong-wei GUAN ; Li-zhi ZHANG ; Qiu-ping ZHANG ; Fa-peng WANG ; Yong-ji LIU

Chinese Journal of Surgery 2003;41(2):81-83

6.Insulin Receptor Expression in Clear Cell Renal Cell Carcinoma and Its Relation to Prognosis.

Sayamaa LKHAGVADORJ ; Sung Soo OH ; Mi Ra LEE ; Jae Hung JUNG ; Hyun Chul CHUNG ; Seung Kuy CHA ; Minseob EOM

Yonsei Medical Journal 2014;55(4):861-870

7.Insulin Receptor Expression in Clear Cell Renal Cell Carcinoma and Its Relation to Prognosis.

Sayamaa LKHAGVADORJ ; Sung Soo OH ; Mi Ra LEE ; Jae Hung JUNG ; Hyun Chul CHUNG ; Seung Kuy CHA ; Minseob EOM

Yonsei Medical Journal 2014;55(4):861-870

8.Clinicopathologic features and differential diagnosis of multilocular cystic renal cell carcinoma.

Wei ZHANG ; Yujun LI ; Qing LU ; Jie ZHUANG ; Qiang WANG ; Hui ZHAO ; Wenjuan YU ; Enhao KANG ; Zengwen FENG

Chinese Journal of Pathology 2014;43(11):723-727

10.Innate immune checkpoint Siglec10 in cancers: mining of comprehensive omics data and validation in patient samples.

Chen ZHANG ; Jiandong ZHANG ; Fan LIANG ; Han GUO ; Sanhui GAO ; Fuying YANG ; Hua GUO ; Guizhen WANG ; Wei WANG ; Guangbiao ZHOU

Frontiers of Medicine 2022;16(4):596-609

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 110 , 1/11 Show Home Prev Next End page: GO